A quarter of people with HCV initially refused access to sofosbuvir/lepidasvir

A quarter of people with HCV initially refused access to sofosbuvir/lepidasvir … Treatment of HCV infection has been revolutionised by the development of direct-acting antiviral (DDA) agents. Compared to traditional therapy with pegylated interferon/ribavirin, treatment with DDAs is associated with … Continue reading

White House Is Pressed to Help Widen Access to Hepatitis C Drugs via Medicaid

White House Is Pressed to Help Widen Access to Hepatitis C Drugs via Medicaid WASHINGTON — Federal and state Medicaid officials should widen access to prescription drugs that could cure tens of thousands of people with hepatitis C, including medications … Continue reading

As Minnesota insurers limit access to hepatitis C drugs, patients chafe

As Minnesota insurers limit access to hepatitis C drugs, patients chafe RENÉE JONES SCHNEIDER • reneejones@startribune.com Kelly Krodel, right, was diagnosed with hepatitis C soon after her daughter Maddie was born. Because she is healthy, two insurers have denied coverage … Continue reading